Injured Workers Pharmacy Will Pay $11M to Settle Complaint By Mass. AG’s Office

July 6, 2020

Injured Workers Pharmacy, or IWP, improperly dispensed opioids to injured workers after paying attorneys for referrals and contracting with physicians who prescribed drugs to known abusers, the office said. The company did not properly review prescriptions to ensure they were legitimate and engaged in unlawful marketing practices to boost sales, the complaint says.

“They dispensed thousands of prescriptions for dangerous drugs, including opioids like fentanyl, with a shocking lack of regard for whether those prescriptions were legitimate,” Healey said in a press release. “Combatting the opioid epidemic remains a top priority of my office and we will aggressively pursue those who break our laws to profit from this crisis.”

IWP is a familiar name to workers’ compensation insurance adjusters because it dispenses medications even for claims that have not been accepted as compensable, complicating settlement negotiations. The company, founded in 2001, has filed lawsuits against CompSource Mutual Insurance Co. and New York City seeking reimbursement for alleged “underpayments” for the drugs it delivered to workers’ compensation claimants.

The complaint by Healey’s office says that IWP used unlawful tactics to drive sales, including entering into illegal agreements to buy patient referrals and offering incentives to sales staff to engage in their own misconduct and ignore red flags by paying them based on dispensing volume.

The complaint alleges IWP filled and shipped:

  • Thousands of prescriptions written by problem prescribers who were ultimately disciplined, indicted or convicted for improper opioid prescribing.
  • Thousands of dangerous, high-dose prescriptions, including for fentanyl formulations known to be especially dangerous.
  • Thousands of prescriptions for dangerous drug combinations known to be indicators of drug misuse and potential overdose, including the so-called “holy trinity” – a combination of an opioid, a benzodiazepine, and a muscle relaxant.

IWP entered into a consent judgment that requires it to hire additional staff and change its operations and business practices. Among the required measures, IWP must:

  • Hire a full-time compliance officer to assess whether to block and report prescribers and design and administer training programs to teach IWP staff about red flag prescribing behaviors.
  • Hire a data analyst to review dispensing data to identify at-risk patients and suspicious prescribers and a pain management specialty pharmacist to counsel at-risk patients and their doctors.
  • Consult state prescription drug monitoring programs prior to dispensing controlled substance prescriptions.
  • Offer to dispense naloxone to all patients receiving Schedule II and III controlled substances, including opioids, at no out-of-pocket cost to the patient.
  • Stop making unlawful payments for referrals.

IWP did not admit to any wrongdoing when it agreed to the consent judgment. The company announced on its website the launch of a new compliance program following the attorney general’s “recent review” of its business practices.

“We will continue to assess and evolve our practices in the best interest of our patients and in compliance with state and federal regulations,” the company said.

Was this article valuable?

Here are more articles you may enjoy.